Not a good buy right now for an impatient entry: LEA is extended/overbought (RSI-6 80) and is trading right into/just above a key resistance zone (132.52), which often leads to quick pullbacks.
Earnings/news flow is clearly supportive (Q4 beat and upbeat 2026 outlook), but the technical setup suggests you’re paying a near-term premium after the post-earnings move.
Options positioning is bullish (very low put/call volume ratio) and activity is elevated, which can support momentum, but it also increases the odds you’re late to the move.
Trend/Momentum: MACD histogram is positive and expanding (bullish momentum intact), and moving averages are converging (potential inflection/expansion phase).
Overbought: RSI_6 at 80.36 signals short-term overbought conditions (higher chance of a dip or consolidation).
Levels: Pivot 124.49; immediate resistance R1 132.523 (price is ~133 pre-market, i.e., right at/just above resistance); next resistance R2 137.487; support S1 116.457.
Practical read: momentum is up, but entry quality is poor at this exact level because you’re buying into resistance with an overbought RSI.
Options Data
Bullish
Open Interest Put-Call Ratio
Bullish
Option Volume Put-Call Ratio
Sentiment: Put/Call OI ratio 0.61 and extremely low put/call volume ratio 0.05 indicate bullish skew (calls dominating).
Positioning/flow: Today’s option volume (204) is ~551% of the 30-day average (unusually active), suggesting post-earnings interest.
Volatility: IV30 ~35.35 vs HV ~39.82 (IV slightly below realized); IV percentile ~62.55 (not cheap, not extreme).
Takeaway: Options market is leaning bullish, but the surge in activity can also mean the “easy” post-event move may already be priced.
Technical Summary
Sell
5
Buy
11
Positive Catalysts
Q4 2025 results: revenue up ~5% YoY to ~$6.0B; Non-GAAP EPS reported at 3.41 (notably above the pre-print consensus cited at 2.80).
2026 outlook: projected net sales ~$23.21B–$24.01B (supports forward narrative).
Business momentum: >$1.4B in new business awards mentioned in news summary.
Pattern-based stock trend input suggests favorable odds for upside over 1D/1W/1M (as provided).
Neutral/Negative Catalysts
increases near-term pullback risk.
Financial Performance
Latest quarter: 2025/Q4.
Revenue: $5.9886B, +4.79% YoY (top-line growth is positive).
Net income: $82.7M, -6.13% YoY (earnings quality/profit conversion softened).
Bottom line: growth is present, but margin/profit trends are the main blemish despite the upbeat forward commentary.
Growth
Profitability
Efficiency
Analyst Ratings and Price Target Trends
Recent direction: price targets have been raised post-earnings/into 2026 outlook updates.
Citi (2026-02-05): raised PT to $177 from $146; maintains Buy; views Q4 and 2026 outlook as positive.
Barclays (2026-02-05): raised PT to $140 from $127; maintains Equal Weight.
Mixed/tempered view remains: Morgan Stanley previously downgraded to Equal Weight (2025-12-08) citing a more cautious 2026 backdrop (EV “winter”), while others have nudged targets higher.
Wall Street pros/cons summary: Pros—improving targets and at least one strong Buy view (Citi) driven by outlook and cycle recovery leverage; Cons—several major firms remain neutral/Equal Weight, implying upside exists but not a “can’t-miss” setup at current levels.
Politicians/congress: No recent congress trading data available (no confirmed politician/influential trading signal in the provided data).
Wall Street analysts forecast LEA stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for LEA is 125.86 USD with a low forecast of 112 USD and a high forecast of 146 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
8 Analyst Rating
Wall Street analysts forecast LEA stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for LEA is 125.86 USD with a low forecast of 112 USD and a high forecast of 146 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
2 Buy
6 Hold
0 Sell
Hold
Current: 136.050
Low
112
Averages
125.86
High
146
Current: 136.050
Low
112
Averages
125.86
High
146
Morgan Stanley
Andrew Percoco
Equal Weight
maintain
$112 -> $123
AI Analysis
2026-02-05
New
Reason
Morgan Stanley
Andrew Percoco
Price Target
$112 -> $123
AI Analysis
2026-02-05
New
maintain
Equal Weight
Reason
Morgan Stanley analyst Andrew Percoco raised the firm's price target on Lear to $123 from $112 and keeps an Equal Weight rating on the shares after the company delivered strong quarterly results and gave 2026 guidance that was broadly in line with expectations, though the firm notes the company's commitment to the buyback exceeded its expectations.
TD Cowen
Itay Michaeli
Hold
maintain
$117 -> $133
2026-02-05
New
Reason
TD Cowen
Itay Michaeli
Price Target
$117 -> $133
2026-02-05
New
maintain
Hold
Reason
TD Cowen analyst Itay Michaeli raised the firm's price target on Lear to $133 from $117 and keeps a Hold rating on the shares. The firm said they remain on the sidelines following an encouraging Q4 highlighted by conquest wins, a strong FCF guide and confident tone from management.
Unlock Full Analyst Thesis， Get the complete breakdown of rating reason for LEA
